Tybriva
Tybriva Products are primarily used for
Blood cancer (Chronic lymphocytic leukemia), Mantle-cell lymphoma
About Tybriva Products
Uses of Tybriva Products
Ibrutinib is used in the treatment of blood cancer (chronic lymphocytic leukemia) and mantle-cell lymphoma. It is also used in chronic lymphocytic leukaemia who have received at least one prior therapy or with 17p deletion.
Tybriva Products side effects
Common
Side Effects of Tybriva are Fever, Headache, Fatigue, Musculoskeletal (bone, muscle or joint) pain, Rash, Anemia (low number of red blood cells), Bruising, Muscle spasm, Hemorrhage, Pneumonia, Cough, Diarrhea, Stomatitis (Inflammation of the mouth), Nausea, Low blood platelets, Decreased white blood cell count (neutrophils), Dry eye, High blood pressure, Weight loss, Urinary tract infection, Peripheral edema, Subdural hematoma, Second primary malignancies.
Severe
Side Effect of Tybriva is Tumor lysis syndrome.
How Tybriva Products work
Ibrutinib is a Bruton's tyrosine kinase inhibitor. It works by blocking the action of the abnormal protein that signals cancer cells to multiply. This helps to stop or slow the spread of cancer cells.